Software and biotech patent reform

A report for the U.S. Congress takes on the problems present in software and biotechnology patents, and makes some recommendations for reform. The report concludes: The multiplicity of patents involved in computer-related products has resulted in the extensive use of cross licensing in these industries such that one commentator argues: Read more

By Andres Guadamuz, ago

Patently MAD

I must admit that I just came across the Open Invention Network (OIN). This is a company created last year by IBM, Novell, Philips, Red Hat, and Sony. Its purpose is to act as a patent pool which will accumulate a number of software patents that will be cross-licensed to Read more

By Andres Guadamuz, ago

Attack of the patent trolls

The world’s favourite patent troll, NTP, is back in court trying to bump Blackberry makers RIM Ltd. out of the market. Welcome to the wacky world of the American patent system, where innovators are punished for being first in the market while a patent shell company gets all their profits. Read more

By Andres Guadamuz, ago

Porn recognition software?

The USPTO continues to amaze me. I mean, one would hope that any silly patent that can be awarded has already been granted. How could it get any worse? Regard US Patent 6,751,348 for protecting an “Automated detection of pornographic images “. The abstract states that the patent covers: A Read more

By Andres Guadamuz, ago

Software Patent Directive round II

(Thanks to Hector MacQueen for the link) IP Watch is reporting that a group of pro-software patent lobbyists and big industry representatives are intent in proposing that there should be another attempt to pass a European directive allowing the patentability of software (pardon me, the patentability of computer implemented inventions). Read more

By Andres Guadamuz, ago

The high cost of patents

The EPO has just released a study conducted in 2004 by consulting firm Roland Berger Market Research on the cost of patenting in Europe. According to the study, an average EPO patent costs €30,530 EUR, where the costs are higher for Japanese and American companies validating in Europe. As further Read more

By Andres Guadamuz, ago